All Stories

  1. Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies
  2. Identification of hsa_circ_0005654 as a new early biomarker of gastric cancer
  3. Using tRNA halves as novel biomarkers for the diagnosis of gastric cancer
  4. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker
  5. Identification and functional annotation of metabolism-associated lncRNAs and their related protein-coding genes in gastric cancer
  6. Circular RNAs in hepatocellular carcinoma: Functions and implications
  7. Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer
  8. Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values
  9. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection
  10. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers
  11. Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances
  12. Global circular RNA expression profile of human gastric cancer and its clinical significance
  13. Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer
  14. Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma
  15. Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances
  16. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma
  17. Circular RNAs: Biogenesis, properties, roles, and their relationships with liver diseases
  18. Plasma lncRNA‑GACAT2 is a valuable marker for the screening of gastric cancer
  19. Roles of long noncoding RNAs in gastric cancer and their clinical applications
  20. Neuropeptide Y Y1 receptors mediate targeted delivery nanoparticles for breast cancer therapy
  21. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression
  22. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer
  23. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance
  24. The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses
  25. Using circular RNA as a novel type of biomarker in the screening of gastric cancer
  26. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
  27. Lycium Barbarum and Tumors in the Gastrointestinal Tract
  28. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer
  29. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer
  30. Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
  31. miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma
  32. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer
  33. miR-129-1-3p Promote BGC-823 Cell Proliferation by Targeting PDCD2
  34. Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively
  35. miR-129-1-3p inhibits cell migration by targeting BDKRB2 in gastric cancer
  36. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer
  37. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis
  38. Clinical significance of the low expression of FER1L4 in gastric cancer patients
  39. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances
  40. Significance of estrogen receptor subtypes in breast tumorigenesis and progression
  41. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance
  42. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance
  43. Growth inhibitory effects of three miR-129 family members on gastric cancer
  44. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association
  45. Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1
  46. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance
  47. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer
  48. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer
  49. Gastric juice miR-129 as a potential biomarker for screening gastric cancer
  50. Antisense Long Non-Coding RNA in the Regulation of Gene Expression
  51. RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties
  52. Long non-coding RNA expression profile in human gastric cancer and its clinical significances
  53. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer
  54. Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance
  55. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients
  56. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells
  57. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients
  58. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin
  59. Research on Toxicity of Medical Metal and Metallic Oxides Nanomaterials
  60. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers
  61. Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells
  62. Integration of Biochemistry and Molecular Biology as a System Curriculum in Chinese Medical Undergraduates
  63. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism
  64. Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells
  65. Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest
  66. Increased expression of miR-421 in human gastric carcinoma and its clinical association
  67. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide
  68. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli
  69. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance
  70. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues
  71. Detection of miR-106a in gastric carcinoma and its clinical significance
  72. Suppression of C-myc Expression Associates with Anti-Proliferation of Aloe-Emodin on Gastric Cancer Cells
  73. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
  74. Aloe-emodin induces in vitro G2/M arrest and alkaline phosphatase activation in human oral cancer KB cells
  75. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents
  76. Detecting Carcinoma Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Immunomagnetic Beads and RT-PCR
  77. Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin
  78. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells
  79. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction
  80. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers